HKSE - Delayed Quote HKD
INT MEDICAL (1501.HK)
26.150
-0.400
(-1.51%)
At close: 4:08:10 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
851,954
851,954
752,836
585,883
464,675
Cost of Revenue
314,292
314,292
314,766
253,397
188,930
Gross Profit
537,662
537,662
438,070
332,486
275,745
Operating Expense
322,766
322,766
276,608
209,309
161,050
Operating Income
214,896
214,896
161,462
123,177
114,695
Net Non Operating Interest Income Expense
6,678
6,678
8,637
12,590
13,892
Pretax Income
213,384
213,384
175,128
144,468
155,691
Tax Provision
23,335
23,335
21,900
10,635
15,246
Net Income Common Stockholders
191,914
191,914
156,457
131,713
142,960
Diluted NI Available to Com Stockholders
191,914
191,914
156,457
131,713
142,960
Basic EPS
1.10
--
0.92
0.79
0.86
Diluted EPS
1.10
--
0.92
0.78
0.86
Basic Average Shares
164,507
--
165,864
166,000
166,000
Diluted Average Shares
170,678
--
170,864
169,000
166,796
Total Operating Income as Reported
216,209
216,209
178,322
145,286
156,324
Total Expenses
637,058
637,058
591,374
462,706
349,980
Net Income from Continuing & Discontinued Operation
191,914
191,914
156,457
131,713
142,960
Normalized Income
199,059.630
199,059.630
154,994.961
125,751.712
117,052.021
Interest Income
9,108
9,108
11,831
13,408
14,525
Interest Expense
2,430
2,430
3,194
818
633
Net Interest Income
6,678
6,678
8,637
12,590
13,892
EBIT
215,814
215,814
178,322
145,286
156,324
EBITDA
295,678
295,678
225,876
182,363
186,540
Reconciled Cost of Revenue
314,292
314,292
314,766
253,397
188,930
Reconciled Depreciation
79,864
79,864
47,554
37,077
30,216
Net Income from Continuing Operation Net Minority Interest
191,914
191,914
156,457
131,713
142,960
Total Unusual Items Excluding Goodwill
-8,023
-8,023
1,671
6,435
28,726
Total Unusual Items
-8,023
-8,023
1,671
6,435
28,726
Normalized EBITDA
303,701
303,701
224,205
175,928
157,814
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-877.370
-877.370
208.961
473.712
2,818.021
12/31/2021 - 11/8/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade